Literature DB >> 15448087

Investigation of the role of B-cells in type 1 diabetes in the NOD mouse.

F Susan Wong1, Li Wen, Michelle Tang, Murugappan Ramanathan, Irene Visintin, Joanne Daugherty, Lynn G Hannum, Charles A Janeway, Mark J Shlomchik.   

Abstract

B-cells are important in the development of type 1 diabetes, but their role is not completely defined. Although B-cells produce autoantibodies, these are not thought to be pathogenic; however, their antigen-presenting function is postulated to be critical. To examine the relative importance of these functions of B-cells, we have generated nonobese diabetic (NOD) B-cell-deficient mice that express a transgene encoding a mutant heavy chain immunoglobulin transgene on the cell surface but cannot secrete immunoglobulins (mIgs). This allowed us to dissect the importance of the relative roles of antigen presentation, dissociated from antibody production. We found that the expression of the mIg transgene increased insulitis and the incidence of diabetes compared with transgene-negative NOD B-cell-deficient mice, indicating that the ability to produce antibodies is not necessary for B-cells to have some effect on the development of diabetes. However, diabetes was not restored to the level seen in normal NOD mice. This may relate to reduced ability to activate an islet-specific T-cell repertoire, presumably due to the reduced islet-specific B-cell repertoire. Our results implicate a specific antigen-presenting function for B-cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448087     DOI: 10.2337/diabetes.53.10.2581

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  94 in total

Review 1.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

2.  Rituximab in Churg-Strauss syndrome.

Authors:  M Koukoulaki; K G C Smith; D R W Jayne
Journal:  Ann Rheum Dis       Date:  2006-04       Impact factor: 19.103

3.  Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice.

Authors:  C Alam; S Valkonen; S Ohls; K Törnqvist; A Hänninen
Journal:  Diabetologia       Date:  2009-11-22       Impact factor: 10.122

Review 4.  Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.

Authors:  C Hu; F S Wong; L Wen
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 5.  Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.

Authors:  Maran L Sprouse; Nicholas A Bates; Krysta M Felix; Hsin-Jung Joyce Wu
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

6.  Relapsing and remitting severe hypoglycemia due to a monoclonal anti-insulin antibody heralding a case of multiple myeloma.

Authors:  F Waldron-Lynch; S E Inzucchi; L Menard; N Tai; P Preston-Hurlburt; P Hui; J McClaskey; W A Hagopian; E Meffre; P W Marks; L Wen; K C Herold
Journal:  J Clin Endocrinol Metab       Date:  2012-10-16       Impact factor: 5.958

Review 7.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

8.  B cell-targeted therapies in autoimmunity: rationale and progress.

Authors:  Paolo Fiorina; Mohamed H Sayegh
Journal:  F1000 Biol Rep       Date:  2009-05-28

9.  Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.

Authors:  Viqar S Banday; Radha Thyagarajan; Mia Sundström; Kristina Lejon
Journal:  Immunology       Date:  2016-08-23       Impact factor: 7.397

10.  Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients.

Authors:  Robert Hilbrands; Volkert A L Huurman; Pieter Gillard; Jurjen H L Velthuis; Marc De Waele; Chantal Mathieu; Leonard Kaufman; Miriam Pipeleers-Marichal; Zhidong Ling; Babak Movahedi; Daniel Jacobs-Tulleneers-Thevissen; Diethard Monbaliu; Dirk Ysebaert; Frans K Gorus; Bart O Roep; Daniel G Pipeleers; Bart Keymeulen
Journal:  Diabetes       Date:  2009-07-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.